Lv0
0 积分 2025-06-30 加入
肥胖患者的长期体重管理及药物临床应用指南(2024版)
1小时前
待确认
Efficacy and safety of once weekly semaglutide 2·4 mg for weight management in a predominantly east Asian population with overweight or obesity (STEP 7): a double-blind, multicentre, randomised controlled trial
1个月前
已完结
Tirzepatide for Weight Reduction in Chinese Adults With Obesity
1个月前
已完结
Tirzepatide versus insulin glargine as second-line or third-line therapy in type 2 diabetes in the Asia-Pacific region: the SURPASS-AP-Combo trial
1个月前
已完结
皖公网安备34019202002308
